Springer Nature AG & Co KGaA (XETRA:SPG) — Market Cap & Net Worth
Market Cap & Net Worth: Springer Nature AG & Co KGaA (SPG)
Springer Nature AG & Co KGaA (XETRA:SPG) has a market capitalization of $208.61K (€178.43K) as of August 1, 2026. Listed on the XETRA stock exchange, this Germany-based company holds position #31185 globally and #2776 in its home market, demonstrating a 4.88% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Springer Nature AG & Co KGaA's stock price €18.50 by its total outstanding shares 9645 (9.64K).
Springer Nature AG & Co KGaA Market Cap History: 2025 to 2026
Springer Nature AG & Co KGaA's market capitalization history from 2025 to 2026. Data shows growth from $215.60K to $208.61K (0.00% CAGR).
Springer Nature AG & Co KGaA Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Springer Nature AG & Co KGaA's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of SPG by Market Capitalization
Companies near Springer Nature AG & Co KGaA in the global market cap rankings as of August 1, 2026.
Key companies related to Springer Nature AG & Co KGaA by market ranking:
- New York Times Company (NYSE:NYT): Ranked #1924 globally with a market cap of $12.06 Billion USD.
- Pearson plc (F:PESA): Ranked #2714 globally with a market cap of $7.47 Billion USD ( €6.39 Billion EUR).
- Schibsted ASA B (OL:SCHB): Ranked #3853 globally with a market cap of $4.37 Billion USD ( Nkr41.56 Billion NOK).
- Springer Nature AG & Co KGaA (F:SPG): Ranked #4066 globally with a market cap of $4.00 Billion USD ( €3.42 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #1924 | New York Times Company | NYSE:NYT | $12.06 Billion | $74.89 |
| #2714 | Pearson plc | F:PESA | $7.47 Billion | €15.00 |
| #3853 | Schibsted ASA B | OL:SCHB | $4.37 Billion | Nkr321.80 |
| #4066 | Springer Nature AG & Co KGaA | F:SPG | $4.00 Billion | €18.34 |
Springer Nature AG & Co KGaA Historical Marketcap From 2025 to 2026
Between 2025 and today, Springer Nature AG & Co KGaA's market cap moved from $215.60K to $ 208.61K, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €208.61K | -3.24% |
| 2025 | €215.60K | -- |
End of Day Market Cap According to Different Sources
On Aug 1st, 2026 the market cap of Springer Nature AG & Co KGaA was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $208.61K USD |
| MoneyControl | $208.61K USD |
| MarketWatch | $208.61K USD |
| marketcap.company | $208.61K USD |
| Reuters | $208.61K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Springer Nature AG & Co KGaA
Springer Nature AG & Co. KGaA operates as a research, educational and professional publisher worldwide. It operates through four segments: research, health, educational, and professional. It publishes science, technical, and medical content through journals and books sells under the Nature Portfolio and Springer brand to research and academic research libraries, libraries of research-intensive in… Read more